Jean-Marc Chapplain
Centre Hospitalier Universitaire de Rennes(FR)
Publications by Year
Research Areas
HIV Research and Treatment, COVID-19 Clinical Research Studies, HIV/AIDS drug development and treatment, Long-Term Effects of COVID-19, Hepatitis C virus research
Most-Cited Works
- → Simultaneous Quantitative Assay of Six HIV Protease Inhibitors, One Metabolite, And Two Non-Nucleoside Reverse Transcriptase Inhibitors in Human Plasma by Isocratic Reversed-Phase Liquid Chromatography(2002)52 cited
- → Is Rifampin Use Associated With Better Outcome in Staphylococcal Prosthetic Valve Endocarditis? A Multicenter Retrospective Study(2020)31 cited
- → Mitochondrial Abnormalities in HIV-Infected Lipoatrophic Patients Treated With Antiretroviral Agents(2004)28 cited
- → Short-Term Decline in All-Cause Acquired Infections With the Routine Use of a Decontamination Regimen Combining Topical Polymyxin, Tobramycin, and Amphotericin B With Mupirocin and Chlorhexidine in the ICU(2013)26 cited
- → Differential effect of ritonavir and indinavir on immune response to hepatitis C virus in HIV-1 infected patients(1999)25 cited
- → The use of drug resistance algorithms and genotypic inhibitory quotient in prediction of lopinavir–ritonavir treatment response in human immunodeficiency virus type 1 protease inhibitor-experienced patients(2007)22 cited
- → Likely effect of the 2014 Ebola epidemic on HIV care in Liberia(2015)22 cited
- → Prevalence of and risk factors for acute mountain sickness among a cohort of high-altitude travellers who received pre-travel counselling(2014)21 cited
- → Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study(2015)20 cited
- → Retention in care for HIV-infected patients in the eye of the Ebola storm(2015)19 cited